• P. N. Patsalos


Piracetam (Fig. 1) corresponds chemically to 2-oxo-1-pyrrolidine acetamide with an empirical formula of C6H10N2O2 and a molecular weight of 142.2.


Plasma Protein Inhibition Potential Valproic Acid Oral Ingestion Empirical Formula 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1. 
    Summary of product characteristics-piracetam. UCB Pharma Ltd. Last update 25 Jan 2011.Google Scholar
  2. 2. 
    Obeso JA, Artieda J, Quinn N, Rothwell JC, Luquin MR, Vaamonde J, Marsden CD. Piracetam in the treatment of different types of myoclonus. Clin Neuropharmacol. 1988;11:529–36.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • P. N. Patsalos
    • 1
    • 2
  1. 1.UCL-Institute of Neurology Department of Clinical and Experimental EpilepsyLondonLondon
  2. 2.Epilepsy Society Chalfont Centre for EpilepsyBuckinghamshireUK

Personalised recommendations